Skip to main content
Top
Published in: Surgery Today 10/2012

01-10-2012 | Original Article

Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-d-glucose (FDG) in FDG-positron emission tomography

Authors: Yasushi Domeki, Erena Yamazaki, Akira Matsuura, Kazuhiro Kitajima, Koji Murakami, Hiroyuki Kato

Published in: Surgery Today | Issue 10/2012

Login to get access

Abstract

Purposes

The physiological accumulation of fluoro-2-deoxy-d-glucose (FDG) is common in medical examinations of the digestive tract conducted using FDG-positron emission tomography (PET). The aim of this study was to determine the effects of a proton pump inhibitor (PPI) on the physiological FDG accumulation in the digestive tract.

Methods

A total of 130 patients examined from July 2007 to October 2008 were included in the final analysis. A PPI was administered orally prior to FDG-PET in 65 patients. The remaining 65 patients underwent FDG-PET without administration of the PPI. The assessments used visual and quantitative evaluations.

Results

Visual evaluation showed that physiological FDG accumulation in the stomach was significantly reduced (p = 0.037) in the PPI group compared with the control group. The quantitative evaluation also revealed a significant reduction in the maximum standardized uptake values (SUVmax) in the stomach in the PPI group compared with the control group (p < 0.0001). Physiological FDG accumulation in the colon showed a decreasing trend on visual evaluation in the PPI group compared with the control group, and the quantitative evaluation found a significant reduction in the physiological FDG accumulation in the colon in the PPI group (p = 0.045).

Conclusions

The oral administration of a PPI was effective for reducing the physiological accumulation of the FDG in the alimentary tract. However, based on the error associated with SUVmax measurement, a quantitative evaluation should therefore be combined with the visual evaluation.
Literature
1.
go back to reference Inoue T, Oriuchi N, Kunio M, Tomiyoshi K, Tomaru Y, Aoyagi K, et al. Accuracy of standardized uptake value measured by simultaneous emission and transmission in scanning in PET oncology. Nucl Med Commun. 1999;20:849–57.CrossRefPubMed Inoue T, Oriuchi N, Kunio M, Tomiyoshi K, Tomaru Y, Aoyagi K, et al. Accuracy of standardized uptake value measured by simultaneous emission and transmission in scanning in PET oncology. Nucl Med Commun. 1999;20:849–57.CrossRefPubMed
2.
go back to reference Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, et al. Mechanisms related to 18F fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. J Nucl Med. 1999;40:339–46.PubMed Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, et al. Mechanisms related to 18F fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. J Nucl Med. 1999;40:339–46.PubMed
3.
go back to reference Luketich JD, Friedman DM, Weigel TL, Meehan MA, Keenan RJ, Townsend DW, et al. Evaluation of distant metastasis in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg. 1999;68:1133–7.CrossRefPubMed Luketich JD, Friedman DM, Weigel TL, Meehan MA, Keenan RJ, Townsend DW, et al. Evaluation of distant metastasis in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg. 1999;68:1133–7.CrossRefPubMed
4.
go back to reference Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743–52.CrossRefPubMedPubMedCentral Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743–52.CrossRefPubMedPubMedCentral
5.
go back to reference Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, et al. Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology. 1992;182:549–52.CrossRefPubMed Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, et al. Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology. 1992;182:549–52.CrossRefPubMed
6.
go back to reference Flamen P, Hoekstra OS, Homans F, Van Cutsem E, Maes A, Stroobants S, et al. Unexplained rising carcinoembryonic antigen (CEA) in the post operative surveillance of colorectal cancer: the utility of positron emission tomography. Eur J Cancer. 2001;37:862–9.CrossRefPubMed Flamen P, Hoekstra OS, Homans F, Van Cutsem E, Maes A, Stroobants S, et al. Unexplained rising carcinoembryonic antigen (CEA) in the post operative surveillance of colorectal cancer: the utility of positron emission tomography. Eur J Cancer. 2001;37:862–9.CrossRefPubMed
7.
go back to reference Tanaka T, Kawai Y, Kanai M, Taki Y, Nakamoto Y, Takabayashi A. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg. 2002;184:433–6.CrossRefPubMed Tanaka T, Kawai Y, Kanai M, Taki Y, Nakamoto Y, Takabayashi A. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg. 2002;184:433–6.CrossRefPubMed
8.
go back to reference Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P. The impact of FDG-PET on the management of algorithm for recurrent colorectal cancer. Eur J Nucl Med. 2001;28:1758–65.CrossRefPubMed Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P. The impact of FDG-PET on the management of algorithm for recurrent colorectal cancer. Eur J Nucl Med. 2001;28:1758–65.CrossRefPubMed
9.
go back to reference Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. Anatometabolic tumor imaging: fusion of FDG-PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190–7.PubMed Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. Anatometabolic tumor imaging: fusion of FDG-PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190–7.PubMed
10.
go back to reference Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG-PET imaging; physiologic and benign variants. Radiographics. 1999;19:61–77.CrossRefPubMed Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG-PET imaging; physiologic and benign variants. Radiographics. 1999;19:61–77.CrossRefPubMed
11.
go back to reference Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med. 1998;23:3–7.CrossRefPubMed Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med. 1998;23:3–7.CrossRefPubMed
12.
go back to reference Yasuda S, Takahashi W, Takagi S, Fujii H, Ide M, Shohtsu A. Factors influencing physiological FDG uptake in the intestine. Tokai J Exp Clin Med. 1998;23:241–4.PubMed Yasuda S, Takahashi W, Takagi S, Fujii H, Ide M, Shohtsu A. Factors influencing physiological FDG uptake in the intestine. Tokai J Exp Clin Med. 1998;23:241–4.PubMed
13.
go back to reference Emmott J, Sanghera B, Chambers J, Wong W. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun. 2008;29:11–6.CrossRefPubMed Emmott J, Sanghera B, Chambers J, Wong W. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun. 2008;29:11–6.CrossRefPubMed
14.
go back to reference de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98–101.CrossRefPubMed de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98–101.CrossRefPubMed
15.
go back to reference Kamimura K, Fujita S, Nishii R, Wakamatsu H, Nagamachi S, Yano T, et al. An analysis of the physiological FDG uptake in the stomach with the water gastric distention method. Eur J Nucl Med Mol Imaging. 2007;34:1815–8.CrossRefPubMed Kamimura K, Fujita S, Nishii R, Wakamatsu H, Nagamachi S, Yano T, et al. An analysis of the physiological FDG uptake in the stomach with the water gastric distention method. Eur J Nucl Med Mol Imaging. 2007;34:1815–8.CrossRefPubMed
16.
go back to reference Morii M, Takata H, Fujisaki H, Takeguchi N. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18–5364 to inhibit gastric H+, K(+)-ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol. 1990;39:661–7.CrossRefPubMed Morii M, Takata H, Fujisaki H, Takeguchi N. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18–5364 to inhibit gastric H+, K(+)-ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol. 1990;39:661–7.CrossRefPubMed
17.
go back to reference Yamamoto F, Nakada K, Zhao S, Satoh M, Asaka M, Tamaki N. Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat. Ann Nucl Med. 2004;18:637–40.CrossRefPubMed Yamamoto F, Nakada K, Zhao S, Satoh M, Asaka M, Tamaki N. Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat. Ann Nucl Med. 2004;18:637–40.CrossRefPubMed
18.
go back to reference Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol. 1995;20:S93–6.CrossRefPubMed Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol. 1995;20:S93–6.CrossRefPubMed
19.
go back to reference Suzuki M, Mori M, Fukumura D, Suzuki H, Miura S, Ishii H, et al. Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extract of Helicobactor pylori. J Gastroenterol Hepatol. 1999;14:27–31.CrossRefPubMed Suzuki M, Mori M, Fukumura D, Suzuki H, Miura S, Ishii H, et al. Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extract of Helicobactor pylori. J Gastroenterol Hepatol. 1999;14:27–31.CrossRefPubMed
20.
go back to reference Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245. Gut. 1992;33:617–21.CrossRefPubMedPubMedCentral Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245. Gut. 1992;33:617–21.CrossRefPubMedPubMedCentral
21.
go back to reference Yoshida N, Yosikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000;14:74–81.CrossRefPubMed Yoshida N, Yosikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000;14:74–81.CrossRefPubMed
22.
go back to reference Okabe S, Higaki E, Higuchi T, Sato M, Hara K. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor. Jpn J Pharmacol. 1986;40:239–49.CrossRefPubMed Okabe S, Higaki E, Higuchi T, Sato M, Hara K. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor. Jpn J Pharmacol. 1986;40:239–49.CrossRefPubMed
23.
go back to reference Okabe S, Takagi K, Inoue K. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol. 1993;62:25–33.CrossRefPubMed Okabe S, Takagi K, Inoue K. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol. 1993;62:25–33.CrossRefPubMed
Metadata
Title
Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-d-glucose (FDG) in FDG-positron emission tomography
Authors
Yasushi Domeki
Erena Yamazaki
Akira Matsuura
Kazuhiro Kitajima
Koji Murakami
Hiroyuki Kato
Publication date
01-10-2012
Publisher
Springer Japan
Published in
Surgery Today / Issue 10/2012
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0265-y

Other articles of this Issue 10/2012

Surgery Today 10/2012 Go to the issue